David A. Dodd | Chairman and Chief Executive Officer |
Mark Reynolds | Chief Financial Officer |
Mark Newman | Chief Scientific Officer |
John W. Sharkey | Head, Business Development |
Kelly McKee | Chief Medical Officer |
Jules Abraham | CORE, Investor Relations |
Joanne Lee | Maxim Group |
Jeffrey Kraws | Crystal Research Associates, LLC |
Michael Okunewitch | Maxim Group |
Good afternoon and welcome everyone to the GeoVax first-quarter 2022, Corporate Update Call. I am Chuck with course call, and I will facilitate today's call. With me are David Dodd, Chairman and CEO, Mr. Mark Reynolds, Chief Financial Officer, Mr. Mark Newman, PhD, Chief Scientific Officer, and Mr.